Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits

Biological Psychiatry

Volumn 54, Issue 9, 2003, Pages 922-928

  Wernicke, Catrin ^a   Samochowiec, Jerzy ^b   Schmidt, Lutz G ^c   Winterer, Georg ^d   Smolka, Michael ^a   Kucharska Mazur, Jolanta ^b   Horodnicki, Jan ^b   Gallinat, Jürgen ^a   Rommelspacher, Hans ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alcoholism; FRET probes; GRIN1; GRIN2B; TDT; Withdrawal

Indexed keywords

ALCOHOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLELE; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DELIRIUM TREMENS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE;

EID: 0042232627     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00072-6     Document Type: Article

References (26)

1. Anders D.L., Blevins T., Smothers C.T., Woodward J.J. Reduced ethanol inhibition of N-methyl-D-aspartate receptors by deletion of the NR1 C0 domain or overexpression of α-actinin-2 proteins. J Biol Chem. 275:2000;15019-15024.
2. Chen X., Moore-Nichols D., Nguyen H., Michaelis E.K. Calcium influx through NMDA receptors, chronic receptor inhibition by ethanol and 2-amino-5-phosphonopentanoic acid, and receptor protein expression. J Neurochem. 72:1999;1969-1980.
3. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
4. Crews F.T., Morrow A.L., Criswell H., Breese G. Effects of ethanol on ion channels. Int Rev Neurobiol. 39:1996;283-367.
5. Grant K.A., Snell L.D., Rogawski M.A., Thurkauf A., Tabakoff B. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (±)-5aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCL) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Ther. 260:1992;1017-1022.
6. Grant K.A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol. 176:1990;289-296.
7. Hesselbrock V.M. The genetic epidemiology of alcoholism. Begleiter H., Kissin B. The Genetics of Alcoholism. 1995;17-39 Oxford University Press, Oxford, UK.
8. Hu X.J., Follesa P., Ticku M.K. Chronic ethanol treatment produces a selective up-regulation of the NMDA receptor subunit gene expression in mammalian cultured cortical neurons. Brain Res Mol Brain Res. 36:1996;211-218.
9. Kendler K.S., Walters E.E., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. The structure of the genetic and environmental risk factor for six major psychiatric disorders in women: Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry. 152:1995;374-383.
10. Liljequist S. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizure. Eur J Pharmacol. 192:1991;197-198.
11. Lovinger D. Examination of ethanol, spermine and acamprosate actions on native and recombinant NMDA receptors. Alcohol Clin Exp Res. 24:(suppl):2000;183A.
12. Mandich P., Schito A.M., Bellone E., Antonacci R., Finelli P., Rocchi M., Ajmar F. Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12. Genomics. 22:1994;216-218.
13. Miller S.A., Dykes D.D., Plesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
14. Miyakawa T., Yagi T., Kitazawa H. Fyn-kinase as a determinant of ethanol sensitivity Relation to NMDA-receptor function . Science. 278:1997;698-701.
15. Nishigushi N., Shirakawa O., Ono H., Hashimoto T., Maeda K. Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit. Analysis of association with schizophrenia. Am J Psychiat. 157:2000;1329-1331.
16. Ohtsuki T., Sakurai K., Dou H., Toru M., Yamakawa-Kobayashi K., Arinami T. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol Psychiatry. 6:2001;211-216.
17. Putzke J., Spanagel R., Toelle T.R., Ziegelgansberger W. The novel anti-craving drug acamprosate alters the expression of NMDAR1 splice variant mRNAs in the rat brain. J Neural Transm. 103:1996;45-46.
18. Rice S.R., Niu N., Berman D.B., Heston L.L., Sobell J.L. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry. 6:2001;274-284.
19. Robins L.N., Wing J., Wittchen H.U., Helzer J.E., Babor T.E., Burke J., et al. The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 45:1988;1069-1077.
20. Ronald K.M., Mirshahi T., Woodward J.J. Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue. J Biol Chem. 276:2001;44729-44735.
21. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Intervies (MINI) The development and validation of a structured diagnostic psychiatric interview for validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 . J Clin Psychiatry. 59:(suppl 20):1998;22-33.
22. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of ethanol withdrawal The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar) . Br J Addict. 84:1989;1353-1357.
23. Thomas M.P., Monaghan D.T., Morrisett R.A. Evidence for a causative role of N-methyl-D-apartate receptors in an in vitro model of alcohol withdrawal hyperexcitability. J Pharmacol Exper Ther. 287:1998;87-97.
24. Tsai G., Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med. 49:1998;173-184.
25. Woodward J.J. Ethanol and NMDA receptor signaling. Neurobiology. 14:2000;69-89.
26. World Health Organization (1992): International classification of diseases. In: Clinical Descriptions and Diagnostic Guidelines, 10th rev ed. Geneva: World Health Organization.